EORTC abstracts at ESMO 2018
15 Oct 2018
Results from a number of EORTC trials will be presented at ESMO2018 Congress in Munich, please see below the title and presenters of the presentations:
Oral Presentation
- An international update of the EORTC questionnaire for assessing quality of life in breast cancer patients (EORTC QLQ-BC23)- EORTC QLQ-BR45
Presentation Number: 193O
Tumour Group: Quality of Life
Speaker: Vesna Bjelic-Radisic (Germany)
Date: 20.10.2018 – Lecture Time: 11:00 – Location: Hall A2 – Room 18
Poster Discussion
- A randomised phase III trial evaluating the addition of denosumab to standard first-line treatment in advanced NSCLC – the ETOP and EORTC SPLENDOUR trial.
Presentation Number 1385PD
Tumour Group: Lung
Poster Presenter: Solange Peters (Switzerland)
Date: 21.10.2018 – Lecture Time 17:15 – Location: ICM – Room 13
- Health-related quality of life in randomized controlled trials: a systematic review of prognostic significance
Presentation Number: 1540PD
Tumour Group: Quality of Life
Speaker: Justyna Mierzynska (Belgium)
Date: 22.10.2018 – Lecture Time: 16:30 – Location: Hall B3 – Room 21
Poster Display Session
- Treatment patterns in elderly patients with locally advanced head and neck squamous cell carcinoma (LA-HNSCC): results from an EORTC led survey
Poster Board Number: 1106P
Tumour Group: Head & Neck
Poster Presenter: Sjoukje Oosting (The Netherlands)
Date: 21.10.2018 – Lecture Time: 13:05 – 13:05 – Location: Hall A3 – Poster Area Networking Hub
- Combined analysis of gene expression profiles in 2 preoperative trials with afatinib and cetuximab in head and neck squamous cell carcinoma
Poster Board Number: 1086P
Tumour Group: Head & Neck
Poster Presenter: Paolo Bossi (Italy)
Date: 21.10.2018 – Lecture Time: 13:05 – Location: Hall B3 – Poster Area
- Health-related quality-of-life results for pembrolizumab versus placebo after complete resection of high-risk stage III melanoma from the EORTC 1325-MG/Keynote 054 trial: an international randomized double-blind phase 3 trial.
Poster Board Number: 1278P
Tumour Group: Quality of Life
Poster Presenter: Corneel Coens (Belgium)
Date: 21.10.2018 – Lecture Time: 13:05 – Location: Hall B3 – Poster Area
Related News
EORTC: Advancing research and treatment for rare cancers
29 Feb 2024
EORTC Fellowship Programme: celebrating more than 20 years of impactful collaboration
22 Feb 2024
Appointment of Malte Peters as EORTC Strategic Alliance Officer
9 Feb 2024
Unique series of workshops in partnership with the European Medicines Agency (EMA)
7 Feb 2024
EORTC launches a prominent clinical trial in older patients with locally advanced (LA) HNSCC (Head and Neck Squamous Cell Carcinoma)
14 Dec 2023
Seven IMMUcan abstracts selected for ESMO Immuno-Oncology Congress 2023
6 Dec 2023
EORTC Quality of Life measures integrated in CDISC
20 Nov 2023
EORTC and Immunocore are collaborating to launch the ATOM clinical trial of tebentafusp in Adjuvant Uveal Melanoma
7 Nov 2023
Treatment with decitabine resulted in a similar survival and fewer adverse events compared with conventional chemotherapy in older fit patients with acute myeloid leukaemia
31 Oct 2023
New results and forthcoming EORTC trials in rare cancers, lung, head and neck, and breast carcinomas presented at ESMO 2023
20 Oct 2023